B Dharani: What Is the N1 Modifiable Cause of PAD in People With Diabetes?
B Dharani, Diabetologist/ General Physician at Dharani Clinic, shared on LinkedIn:
”What Is the N1 Modifiable Cause of PAD in People With Diabetes?
Smoking.
Peripheral arterial disease (PAD) is a major driver of disability, limb loss, and mortality in people with diabetes.
While several factors contribute, smoking remains the most common and powerful modifiable risk factor.
In individuals with diabetes, smoking:
– Accelerates atherosclerosis
– Causes severe endothelial dysfunction
– Increases inflammation and thrombosis
– Further reduces blood flow to already compromised limbs
The combination of diabetes plus smoking leads to:
– Earlier onset of PAD
– Faster disease progression
– Higher risk of ulcers, critical limb ischemia, and amputations
Yes—glycemic control, blood pressure, and lipids are crucial.
But no single modifiable factor worsens PAD outcomes more consistently than smoking.
Key takeaway:
If we aim to prevent PAD progression and limb loss in diabetes, smoking cessation must be prioritized, not treated as an afterthought.
Sometimes, the most effective intervention isn’t a new drug or device—it’s addressing the risk factor doing the most harm.”

Stay updated with Hemostasis Today.
-
Jan 7, 2026, 08:50Fahad Khaliq on When is Ticagrelor Preferred Over Other Antiplatelets
-
Jan 7, 2026, 06:41Zain Khalpey on AI Driven Risk Prediction for Optimization of Anticoagulation in LVAD
-
Jan 7, 2026, 05:47Michael Makris: The Wakley Prize Essay Published in Today’s Lancet is an Excellent Read
-
Jan 7, 2026, 05:36Pierre F Sabouret Shares A Study on the Risk of Cardiovascular Death in SIDs
-
Jan 7, 2026, 05:15Glaivy Batsuli Reflects on ASH25
-
Jan 7, 2026, 05:04Heghine Khachatryan on VWD: A Landmark in the History of Hematology
-
Jan 6, 2026, 13:39JAMA Neurology: No Added Benefit of Dual Therapy After Ischemic Stroke in Case of AFib
-
Jan 6, 2026, 10:10This is Fantastic: Shirley D’Sa on Transfusion-Free Christmas Milestone for 𝛃-Thalassaemia Patient at UCLH
-
Jan 6, 2026, 09:53Hamideh Yadegari: Coagulation–Inflammation Crosstalk: Mechanisms, Pathways, and Clinical Implications
